Managed Care Cast

This week, the top managed care news included the first day of open enrollment; data from CMS that indicate the progress accountable care organizations are making; and findings that most people with obesity aren't get screened for it or getting care.

Read more about the stories in this episode:

Battered but Still on the Books, the ACA Starts a New Round of Open Enrollment: www.ajmc.com/focus-of-the-week/1101/battered-but-still-on-the-books-the-aca-starts-a-new-round-of-open-enrollment

CMS Releases Medicare Shared Savings Program 2016 Results: www.ajmc.com/contributor/travis-broome/2017/10/cms-releases-medicare-shared-savings-program-2016-results

Novartis Seeks Second Indication for Tisagenlecleucel: DLBCL: www.ajmc.com/newsroom/novartis-seeks-second-indication-for-tisagenlecleucel-dlbcl

Most With Obesity Don't Get a Diagnosis or Referral for Care, Study Finds: www.ajmc.com/newsroom/most-with-obesity-dont-get-a-diagnosis-or-referral-for-care-study-finds

Patient-Centered Oncology Care® registration: www.ajmc.com/meetings/pcoc17#register

This week, the top managed care news included a judge ruling President Donald Trump can end the cost-sharing reduction subsidies; findings on awareness of the Choosing Wisely campaign; and conference coverage from around the nation at NAMCP, COA, and more.

Read more about the stories in this episode:

Judge Says Trump Can Block CSR Payments: www.ajmc.com/newsroom/judge-says-trump-can-block-csr-payments

Choosing Wisely Brings Lots of Energy, but No Growth in Awareness: www.ajmc.com/focus-of-the-week/1024/choosing-wisely-brings-lots-of-energy-but-no-growth-in-awareness

COA Payer Exchange Summit VII: www.ajmc.com/conferences/coa-2017-oncology-payment-reform

National Association of Managed Care Physicians Fall Forum 2017: www.ajmc.com/conferences/namcp-fall-2017

VBID Summit Explores How Congress Can Make High-Deductible Plans Work for Consumers: www.ajmc.com/newsroom/vbid-summit-explores-how-congress-can-make-highdeductible-plans-work-for-consumers

Every week, The American Journal of Managed Care recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included the bipartisan deal to stabilize the Affordable Care Act's insurance markets; coverage from the Academy of Managed Care Pharmacy 2017 Nexus; a plan to reduce clinician burnout at the computer; and an FDA advisory panel has recommended approval for semaglutide, a once-weekly GLP-1 receptor agonist.

Read more about the stories in this episode:

Deal Reached to Keep Health Insurance Subsidies: www.ajmc.com/focus-of-the-week/1017/Deal-Reached-to-Keep-Health-Insurance-Subsidies

The Academy of Managed Care Pharmacy Nexus 2017: www.ajmc.com/conferences/amcp-nexus-2017

Kite Pharma's CAR T-Cell Treatment Approved, Cheaper Than Tisagenlecleucel: www.ajmc.com/newsroom/kite-pharmas-car-t-cell-treatment-approved-cheaper-than-tisagenlecleucel

AMA Seeks to Make Health Data Work Better for Doctors, Patients: www.ajmc.com/focus-of-the-week/1017/AMA-Seeks-to-Make-Health-Data-Work-Better-for-Doctors-Patients

ACO & Emerging Healthcare Delivery Coalition Fall 2017: www.ajmc.com/acocoalition/fall17

FDA Panel Gives Nod to Once-Weekly Semaglutide for Type 2 Diabetes: www.ajmc.com/newsroom/fda-panel-gives-nod-to-once-weekly-semaglutide-for-type-2-diabetes

Evidence-Based Oncology, October 2017: www.ajmc.com/journals/evidence-based-oncology/2017/October-2017

As the senior national correspondent at Kaiser Health News, Sarah Varney covers health policy, specifically looking at federal law and how it rolls out in states and local jurisdictions. During her conversation with Patricia Salber, MD, MBA, of The Doctor Weighs In, she explained how her articles are shaped by the time she spends in the field talking to people affected by the policy decisions made in Washington, DC, or state capitals.

This week, the top managed care stories included a new executive order to allow sale of health insurance across state lines; Iowa wait for a response to its request to opt out of parts of the Affordable Care Act; and a new study finds childhood obesity increased 10-fold over 4 decades.

This week, the top managed care stories included speculation regarding who would replace Tom Price, MD, as HHS secretary; a report on breast cancer mortality trends and racial disparities from 1989 to 2015; and the FDA announced new strategies to improve patient access to less expensive drugs.

This week, the top managed care stories included the end of the latest attempt to repeal the Affordable Care Act; a call to include the patient's voice in cancer quality metrics; and an argument for caution regarding the newly approved CAR T-cell therapy, Kymriah.

Recovering from the devastation in hurricane-affected areas will take a long time, as Michael Griffin, president and CEO and Daughters of Charity Services of New Orleans, knows well.

Twelve years after Hurricane Katrina hit the Gulf Coast city, New Orleans is still recovering. In a discussion with Patricia Salber, MD, MBA, of The Doctor Weighs In, Griffin explains his experience in New Orleans, where the recovery currently is, and what lessons he's learned that hard hit areas, like Puerto Rico can take note of during these difficult months and years of rebuilding.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories included a new direction for the Center for Medicare and Medicaid Innovation; a bipartisan group of governors spoke out against the latest effort to repeal the Affordable Care Act; and the World Health Organization warned that antibiotics currently being developed were not enough to fight antibiotic-resistant infections.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top stories in managed care included competing healthcare reform bills in the Senate; the FDA announced progress in clearing up the backlog of orphan drug requests; and a study examines how much it really costs to bring a drug to the market.